ROYAL BANK OF CANADA - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 124 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$10,000
-56.5%
3,012
-49.8%
0.00%
Q2 2018$23,000
+53.3%
6,000
+64.2%
0.00%
Q1 2018$15,000
+25.0%
3,654
+39.8%
0.00%
Q4 2017$12,000
-80.6%
2,613
-70.1%
0.00%
Q3 2017$62,000
-81.7%
8,725
-84.1%
0.00%
Q1 2017$338,000
+3.0%
54,822
-2.2%
0.00%
Q4 2016$328,00056,031
+65052.3%
0.00%
Q3 2016$0
-100.0%
86
-17.3%
0.00%
Q2 2016$1,000
-92.3%
104
-96.2%
0.00%
Q1 2016$13,000
-83.3%
2,704
-82.4%
0.00%
Q4 2015$78,000
-79.5%
15,357
-85.8%
0.00%
Q3 2015$381,000
+97.4%
108,180
+459.5%
0.00%
Q2 2015$193,000
+36.9%
19,334
+74.8%
0.00%
Q1 2015$141,000
-68.2%
11,063
-64.8%
0.00%
Q4 2014$444,000
+26.1%
31,415
+22.9%
0.00%
Q3 2014$352,000
+190.9%
25,569
+225.4%
0.00%
Q2 2014$121,000
+8.0%
7,857
+19.6%
0.00%
Q1 2014$112,000
-80.1%
6,572
-84.9%
0.00%
Q4 2013$562,000
+5520.0%
43,422
+4144.6%
0.00%
Q3 2013$10,0001,0230.00%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Old West Investment Management, LLC 1,068,719$3,633,0001.50%
Abrams Capital Management 9,108,867$30,970,0000.82%
Baupost Group 25,791,678$87,692,0000.67%
Bristol Advisors, LLC 51,100$174,0000.29%
RICE HALL JAMES & ASSOCIATES, LLC 2,228,059$7,575,0000.27%
NEXTHERA CAPITAL LP 200,000$680,0000.13%
LINCOLN CAPITAL CORP 37,280$127,0000.10%
Meridian Wealth Management, LLC 49,600$169,0000.07%
Rubric Capital Management LP 199,883$680,0000.07%
Virtus ETF Advisers LLC 155,009$527,0000.05%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders